Juergen Heß

694 total citations
18 papers, 399 citations indexed

About

Juergen Heß is a scholar working on Oncology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Juergen Heß has authored 18 papers receiving a total of 399 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Immunology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Juergen Heß's work include Immunotherapy and Immune Responses (7 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and CAR-T cell therapy research (5 papers). Juergen Heß is often cited by papers focused on Immunotherapy and Immune Responses (7 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and CAR-T cell therapy research (5 papers). Juergen Heß collaborates with scholars based in Germany, Colombia and Denmark. Juergen Heß's co-authors include Horst Lindhofer, Peter Ruf, Matthias Plöscher, Hans‐Joachim Mollenkopf, Reinhard Liedtke, Patrick Gruber, Peter Andersen, Stefan H. E. Kaufmann, Dirk Chelius and Barbara Schmalfeldt and has published in prestigious journals such as Cancer Research, Vaccine and Food Control.

In The Last Decade

Juergen Heß

17 papers receiving 369 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Juergen Heß Germany 8 196 155 140 124 54 18 399
Catherine A. Rumbley United States 13 88 0.4× 332 2.1× 125 0.9× 127 1.0× 40 0.7× 17 569
Matt Devalaraja United States 5 99 0.5× 141 0.9× 45 0.3× 206 1.7× 59 1.1× 6 393
Lindsay L. Brown United States 6 179 0.9× 98 0.6× 191 1.4× 138 1.1× 17 0.3× 7 404
Mohammad Mehdi Amiri Iran 13 113 0.6× 115 0.7× 130 0.9× 202 1.6× 117 2.2× 66 458
T. Noelle Lombana United States 10 96 0.5× 104 0.7× 164 1.2× 259 2.1× 112 2.1× 13 435
Jim Freeth United States 9 99 0.5× 213 1.4× 69 0.5× 170 1.4× 37 0.7× 10 606
Aws Abdul‐Wahid Canada 14 109 0.6× 151 1.0× 36 0.3× 187 1.5× 73 1.4× 17 447
Karyn McFadden United States 15 129 0.7× 106 0.7× 70 0.5× 214 1.7× 158 2.9× 20 560
Yanal Murad Canada 14 166 0.8× 209 1.3× 106 0.8× 226 1.8× 66 1.2× 26 583

Countries citing papers authored by Juergen Heß

Since Specialization
Citations

This map shows the geographic impact of Juergen Heß's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juergen Heß with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juergen Heß more than expected).

Fields of papers citing papers by Juergen Heß

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juergen Heß. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juergen Heß. The network helps show where Juergen Heß may publish in the future.

Co-authorship network of co-authors of Juergen Heß

This figure shows the co-authorship network connecting the top 25 collaborators of Juergen Heß. A scholar is included among the top collaborators of Juergen Heß based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juergen Heß. Juergen Heß is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
Buhmann, Raymund, Michael Stanglmaier, Juergen Heß, et al.. (2013). Immunotherapy with FBTA05 (Bi20), a trifunctional bispecific anti-CD3 x anti-CD20 antibody and donor lymphocyte infusion (DLI) in relapsed or refractory B-cell lymphoma after allogeneic stem cell transplantation: study protocol of an investigator-driven,. 11. 160. 3 indexed citations
3.
Heß, Juergen, et al.. (2012). 三官能性抗体Catumaxomab(抗EpCAM×Anti-CD3)による治療を受けた悪性腹水患者の第2/3相試験に関する免疫モニタリング結果. Cancer Research. 72(1). 24–32. 1 indexed citations
4.
Ruf, Peter, Beatrix Schäfer, Nina Eißler, et al.. (2012). Ganglioside GD2-specific trifunctional surrogate antibody Surek demonstrates therapeutic activity in a mouse melanoma model. Journal of Translational Medicine. 10(1). 219–219. 24 indexed citations
5.
Jäger, Michael, A. Schoberth, Peter Ruf, et al.. (2011). Immunomonitoring Results of a Phase II/III Study of Malignant Ascites Patients Treated with the Trifunctional Antibody Catumaxomab (Anti-EpCAM × Anti-CD3). Cancer Research. 72(1). 24–32. 88 indexed citations
6.
Heß, Juergen, Peter Ruf, & Horst Lindhofer. (2011). Cancer Therapy with Trifunctional Antibodies: Linking Innate and Adaptive Immunity. Future Oncology. 8(1). 73–85. 18 indexed citations
7.
Chelius, Dirk, Peter Ruf, Patrick Gruber, et al.. (2010). Structural and functional characterization of the trifunctional antibody catumaxomab. mAbs. 2(3). 309–319. 112 indexed citations
8.
Heß, Juergen, et al.. (2007). Advanced Antigen Delivery of Murine Survivin: Chimeric Virus-Like Particles in Cancer Vaccine Research. International Journal of Biomedical Science. 3(3). 199–205. 3 indexed citations
9.
Reiser, Christian O. A., et al.. (2007). Advanced antigen delivery of murine survivin: chimeric virus-like particles in cancer vaccine research.. PubMed. 3(3). 199–205. 3 indexed citations
10.
11.
Reichel, Christoph, et al.. (2006). ImmunoTrack®: The novel antibody‐based technology for tracing in animal health. Biotechnology Journal. 1(6). 625–632. 1 indexed citations
12.
Bickert, Thomas, Gisela Wohlleben, Claudia M. Trujillo‐Vargas, et al.. (2006). Murine polyomavirus-like particles induce maturation of bone marrow-derived dendritic cells and proliferation of T cells. Medical Microbiology and Immunology. 196(1). 31–39. 10 indexed citations
13.
Reichel, Christoph, et al.. (2006). Heterologous Virus-Like-Particles: Recombinant Nanosystems as Versatile Antigen Delivery Devices for Immune Intervention. Current Nanoscience. 2(4). 295–309. 4 indexed citations
14.
Reichel, Christoph, et al.. (2006). Protein-Based Nanosystems: Virus-Like-Particles in Modern Vaccine Development. Journal of Biomedical Nanotechnology. 2(3). 186–200. 2 indexed citations
15.
16.
17.
18.
Mollenkopf, Hans‐Joachim, et al.. (2001). Protective efficacy against tuberculosis of ESAT-6 secreted by a live Salmonella typhimurium vaccine carrier strain and expressed by naked DNA. Vaccine. 19(28-29). 4028–4035. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Catherine A. Rumbley Breakdown of academic impact, for papers by Matt Devalaraja Breakdown of academic impact, for papers by Lindsay L. Brown Breakdown of academic impact, for papers by Mohammad Mehdi Amiri Breakdown of academic impact, for papers by T. Noelle Lombana Breakdown of academic impact, for papers by Jim Freeth Breakdown of academic impact, for papers by Aws Abdul‐Wahid Breakdown of academic impact, for papers by Karyn McFadden Breakdown of academic impact, for papers by Yanal Murad
Rankless by CCL
2026